Autoantibody testing in neuromuscular medicine: assay technologies, interpretation, and clinical utility
- 1 February 2026
- journal article
- review article
- Published by Elsevier in Clinical Biochemistry
- Vol. 142, 111092
Abstract
No abstract availableKeywords
This publication has 142 references indexed in Scilit:
- High‐Throughput Immunoassays for Cavin‐4 IgG: A Diagnostic Tool for Immune‐Mediated Rippling Muscle DiseaseAnnals of Clinical and Translational Neurology, 2025
- Identification of Caveolae-Associated Protein 4 Autoantibodies as a Biomarker of Immune-Mediated Rippling Muscle Disease in AdultsJAMA Neurology, 2022
- Monitoring Clinical Course and Treatment Response in Chronic Inflammatory Demyelinating Polyneuropathy During Routine CareJAMA Neurology, 2020
- Clinical Features and Treatment Outcomes of Necrotizing Autoimmune MyopathyJAMA Neurology, 2015
- Clinical Features and Diagnostic Usefulness of Antibodies to Clustered Acetylcholine Receptors in the Diagnosis of Seronegative Myasthenia GravisJAMA Neurology, 2015
- Presence and Pathogenic Relevance of Antibodies to Clustered Acetylcholine Receptor in Ocular and Generalized Myasthenia GravisArchives of Neurology, 2012
- Clinical Correlations With Dermatomyositis-Specific Autoantibodies in Adult Japanese Patients With DermatomyositisArchives of Dermatology, 2011
- Positron Emission Tomography–Computed Tomography in Paraneoplastic Neurologic DisordersArchives of Neurology, 2010
- Ganglionic Acetylcholine Receptor AutoantibodyArchives of Neurology, 2009
- Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barr syndromeAnnals of Neurology, 1999